Literature DB >> 17220632

Steroid-dependent ACTH-produced thymic carcinoid: regulation of POMC gene expression by cortisol via methylation of its promoter region.

Yoko Mizoguchi1, Teruyuki Kajiume, Shin-ichiro Miyagawa, Satoshi Okada, Yoshikazu Nishi, Masao Kobayashi.   

Abstract

AIMS: Metyrapone causes a decrease in the serum cortisol level without affecting ACTH production in ectopic tumors. We report a case who presented with Cushing's syndrome due to an ectopic ACTH-producing thymic carcinoid. In the present case, it was demonstrated that metyrapone administration resulted in a significant decrease in the plasma ACTH and serum cortisol levels. We hypothesized that the steroid hormone may promote proopiomelanocortin (POMC) gene expression in the carcinoid cells.
METHODS: An 11-year-old boy presented with Cushing's syndrome. Prior to the detection of a thymic tumor, metyrapone was administered to ameliorate the symptoms of Cushing's syndrome. Interestingly, plasma ACTH as well as serum cortisol levels immediately decreased after metyrapone administration. The levels of cortisol and ACTH were observed to be normal after complete surgical resection of the tumor. Biological characterization of the tumor cells was by in vitro analysis.
RESULTS: Thein vitro culture of the tumor cells showed an increased expression of POMC in the presence of cortisol. A CpG methylation assay showed that the demethylation of the POMC promoter was induced by a steroid hormone.
CONCLUSION: These findings suggest that the ectopic ACTH-producing tumor may partly be regulated by the elevated levels of cortisol.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17220632     DOI: 10.1159/000098548

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  10 in total

1.  Prolonged remission after long-term treatment with steroidogenesis inhibitors in Cushing's syndrome caused by ectopic ACTH secretion.

Authors:  S T Sharma; L K Nieman
Journal:  Eur J Endocrinol       Date:  2011-12-21       Impact factor: 6.664

Review 2.  The human POMC gene promoter: where do we stand?

Authors:  F Pecori Giraldi; F Cassarino; L Pagliardini; V Asnaghi; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

3.  Ectopic ACTH-producing neuroendocrine tumor occurring with large recurrent metastatic pheochromocytoma: a case report.

Authors:  Fumi Saishouji; Sarie Maeda; Hideaki Hamada; Noriko Kimura; Ai Tamanoi; Saiko Nishida; Masaji Sakaguchi; Motoyuki Igata; Kiho Yokoo; Fumi Kawakami; Eiichi Araki; Tatsuya Kondo
Journal:  BMC Endocr Disord       Date:  2022-07-19       Impact factor: 3.263

4.  AZA-deoxycytidine stimulates proopiomelanocortin gene expression and ACTH secretion in human pituitary ACTH-secreting tumors.

Authors:  Maria Francesca Cassarino; Antonella Sesta; Luca Pagliardini; Marco Losa; Giovanni Lasio; Francesco Cavagnini; Francesca Pecori Giraldi
Journal:  Pituitary       Date:  2014-10       Impact factor: 4.107

Review 5.  Ectopic Cushing's syndrome due to thymic neuroendocrine tumours: a systematic review.

Authors:  Fernando Guerrero-Pérez; Inmaculada Peiró; Agustina Pia Marengo; Alex Teulé; José Carlos Ruffinelli; Roger Llatjos; Teresa Serrano; Ivan Macia; Nuria Vilarrasa; Pedro Iglesias; Carles Villabona
Journal:  Rev Endocr Metab Disord       Date:  2021-05-07       Impact factor: 6.514

6.  Epigenetics of early child development.

Authors:  Chris Murgatroyd; Dietmar Spengler
Journal:  Front Psychiatry       Date:  2011-04-18       Impact factor: 4.157

7.  Inflammatory-linked changes in CpG island methylation of three opioid peptide genes in a rat model for pain.

Authors:  Charlotte Louise Justine Jacobi; Christoph Stein
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

Review 8.  Epigenetic Pathways in Human Disease: The Impact of DNA Methylation on Stress-Related Pathogenesis and Current Challenges in Biomarker Development.

Authors:  M Austin Argentieri; Sairaman Nagarajan; Bobak Seddighzadeh; Andrea A Baccarelli; Alexandra E Shields
Journal:  EBioMedicine       Date:  2017-04-04       Impact factor: 8.143

9.  Tumor Shrinkage by Metyrapone in Cushing Disease Exhibiting Glucocorticoid-Induced Positive Feedback.

Authors:  Yasutaka Tsujimoto; Hiroki Shichi; Hidenori Fukuoka; Masaaki Yamamoto; Itsuko Sato; Takamitsu Imanishi; Tomoaki Nakamura; Naoko Inoshita; Atsushi Ishida; Shozo Yamada; Yutaka Takahashi; Kazuo Chihara
Journal:  J Endocr Soc       Date:  2021-03-30

10.  Spontaneous adrenocorticotropic hormone (ACTH) normalisation due to tumour regression induced by metyrapone in a patient with ectopic ACTH syndrome: case report and literature review.

Authors:  Hideyuki Iwayama; Sho Hirase; Yuka Nomura; Tatsuo Ito; Hiroyuki Morita; Kazuo Otake; Akihisa Okumura; Junko Takagi
Journal:  BMC Endocr Disord       Date:  2018-03-27       Impact factor: 2.763

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.